1679 related articles for article (PubMed ID: 14722144)
1. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
[TBL] [Abstract][Full Text] [Related]
2. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
You WC; Brown LM; Zhang L; Li JY; Jin ML; Chang YS; Ma JL; Pan KF; Liu WD; Hu Y; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; Xu GW; Gail MH
J Natl Cancer Inst; 2006 Jul; 98(14):974-83. PubMed ID: 16849680
[TBL] [Abstract][Full Text] [Related]
3. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
[TBL] [Abstract][Full Text] [Related]
5. A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication.
Pan KF; Zhang L; Gerhard M; Ma JL; Liu WD; Ulm K; Wang JX; Zhang L; Zhang Y; Bajbouj M; Zhang LF; Li M; Vieth M; Liu RY; Quante M; Wang LH; Suchanek S; Zhou T; Guan WX; Schmid R; Classen M; You WC
Gut; 2016 Jan; 65(1):9-18. PubMed ID: 25986943
[TBL] [Abstract][Full Text] [Related]
6. Effects of
Li WQ; Zhang JY; Ma JL; Li ZX; Zhang L; Zhang Y; Guo Y; Zhou T; Li JY; Shen L; Liu WD; Han ZX; Blot WJ; Gail MH; Pan KF; You WC
BMJ; 2019 Sep; 366():l5016. PubMed ID: 31511230
[TBL] [Abstract][Full Text] [Related]
7. Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma.
Choi J; Kim SG; Yoon H; Im JP; Kim JS; Kim WH; Jung HC
Clin Gastroenterol Hepatol; 2014 May; 12(5):793-800.e1. PubMed ID: 24100112
[TBL] [Abstract][Full Text] [Related]
8. Effect of Helicobacter pylori Eradication on Gastric Cancer Prevention: Updated Report From a Randomized Controlled Trial With 26.5 Years of Follow-up.
Yan L; Chen Y; Chen F; Tao T; Hu Z; Wang J; You J; Wong BCY; Chen J; Ye W
Gastroenterology; 2022 Jul; 163(1):154-162.e3. PubMed ID: 35364066
[TBL] [Abstract][Full Text] [Related]
9. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention.
Lee YC; Chen TH; Chiu HM; Shun CT; Chiang H; Liu TY; Wu MS; Lin JT
Gut; 2013 May; 62(5):676-82. PubMed ID: 22698649
[TBL] [Abstract][Full Text] [Related]
10. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
[TBL] [Abstract][Full Text] [Related]
11. H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole.
Yang HB; Sheu BS; Wang ST; Cheng HC; Chang WL; Chen WY
Am J Gastroenterol; 2009 Jul; 104(7):1642-9. PubMed ID: 19436275
[TBL] [Abstract][Full Text] [Related]
12. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
[TBL] [Abstract][Full Text] [Related]
13. The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer.
Ogura K; Hirata Y; Yanai A; Shibata W; Ohmae T; Mitsuno Y; Maeda S; Watabe H; Yamaji Y; Okamoto M; Yoshida H; Kawabe T; Omata M
J Clin Gastroenterol; 2008 Mar; 42(3):279-83. PubMed ID: 18223496
[TBL] [Abstract][Full Text] [Related]
14. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial.
Fukase K; Kato M; Kikuchi S; Inoue K; Uemura N; Okamoto S; Terao S; Amagai K; Hayashi S; Asaka M;
Lancet; 2008 Aug; 372(9636):392-7. PubMed ID: 18675689
[TBL] [Abstract][Full Text] [Related]
15. Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial.
Choi JM; Kim SG; Choi J; Park JY; Oh S; Yang HJ; Lim JH; Im JP; Kim JS; Jung HC
Gastrointest Endosc; 2018 Sep; 88(3):475-485.e2. PubMed ID: 29800546
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.
Zhang Y; Pan KF; Zhang L; Ma JL; Zhou T; Li JY; Shen L; You WC
Carcinogenesis; 2015 Dec; 36(12):1572-9. PubMed ID: 26449252
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data.
Muñoz N; Vivas J; Buiatti E; Kato I; Oliver W
IARC Sci Publ; 1996; (139):125-33. PubMed ID: 8923024
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori eradication for the prevention of gastric neoplasia.
Ford AC; Yuan Y; Forman D; Hunt R; Moayyedi P
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD005583. PubMed ID: 32628791
[TBL] [Abstract][Full Text] [Related]
19. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality.
Ma JL; Zhang L; Brown LM; Li JY; Shen L; Pan KF; Liu WD; Hu Y; Han ZX; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; You WC; Gail MH
J Natl Cancer Inst; 2012 Mar; 104(6):488-92. PubMed ID: 22271764
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
